“Concerns about safety have long dogged antidepressants. In 2006, the makers of Paxil upgraded their warning label to caution that among adults of all ages with major depressive disorder, the frequency of suicidal behavior was higher in patients treated with paroxetine (Paxil) compared with placebo — 6.7 times higher.”